Wealth Trak Capital Management LLC Denali Therapeutics Inc. Transaction History
Wealth Trak Capital Management LLC
- $118 Billion
- Q4 2024
A detailed history of Wealth Trak Capital Management LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Wealth Trak Capital Management LLC holds 10 shares of DNLI stock, worth $208. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10Holding current value
$208% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding DNLI
# of Institutions
238Shares Held
121MCall Options Held
60.6KPut Options Held
48.4K-
Black Rock Inc. New York, NY13.2MShares$274 Million0.01% of portfolio
-
Baillie Gifford & CO12.3MShares$256 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$250 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA9.85MShares$205 Million0.04% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.91MShares$165 Million0.05% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $2.79B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...